Roche's Tecentriq wins U.S. approval for aggressive breast cancer

México Noticias Noticias

Roche's Tecentriq wins U.S. approval for aggressive breast cancer
México Últimas Noticias,México Titulares
  • 📰 Reuters
  • ⏱ Reading Time:
  • 21 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

Roche won U.S. approval on Friday of its immunotherapy Tecentriq to treat a sign...

FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann

The U.S. Food and Drug Administration approved Tecentriq mixed with the chemotherapy Abraxane to treat inoperable, locally advanced or metastatic triple-negative breast cancer in people whose tumors express PD-L1, a protein that may help cancers avoid detection by the immune system.The FDA’s approval was based on the drug cocktail’s record in studies that showed it delayed the progression of the disease.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Reuters /  🏆 2. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Kevin Roche Imagined Work Spaces to Make Office Life LivelierKevin Roche Imagined Work Spaces to Make Office Life LivelierIrish-born architect Kevin Roche, who died March 1 at age 96, was celebrated as a designer of quirky corporate headquarters that featured indoor gardens concealed parking spaces and rooftop green spaces.
Leer más »

Kevin Roche, leading corporate architect of postwar boom years, dies at 96Kevin Roche, leading corporate architect of postwar boom years, dies at 96He also became an architect of choice for the Metropolitan Museum of Art and other major institutions.
Leer más »

Pritzker Prize, Irish-born architect Kevin Roche diesPritzker Prize, Irish-born architect Kevin Roche diesAcclaimed Irish-born architect Kevin Roche dies, leaving his mark on world-class buildings from New York's Metropolitan Museum of Art and the city's Museum of Jewish Heritage to airports in New York and Washington.
Leer más »

We just got an inside look at the dramatic 10 weeks that sealed a cutting-edge, $4.8 billion biotech acquisitionWe just got an inside look at the dramatic 10 weeks that sealed a cutting-edge, $4.8 billion biotech acquisitionThe biotech Spark played its suitor, Roche, off against another interested buyer to boost the size of the proposed deal by more than 60%.
Leer más »

US Aid Cuts Are Making It Harder For Palestinian Women To Treat Their Breast CancerUS Aid Cuts Are Making It Harder For Palestinian Women To Treat Their Breast CancerMore than 1,000 women who had mammograms done through a US-funded program and were flagged for follow-ups have had to seek other treatment options.
Leer más »

J&J nasal spray gets U.S. approval as first new type of anti-depressant in decadesJ&J nasal spray gets U.S. approval as first new type of anti-depressant in decadesThe U.S. Food and Drug Administration on Tuesday said it approved a Johnson & Jo...
Leer más »

Kevin Roche Imagined Work Spaces to Make Office Life LivelierKevin Roche Imagined Work Spaces to Make Office Life LivelierIrish-born architect Kevin Roche, who died March 1 at age 96, was celebrated as a designer of quirky corporate headquarters that featured indoor gardens concealed parking spaces and rooftop green spaces.
Leer más »

Pritzker Prize, Irish-born architect Kevin Roche diesPritzker Prize, Irish-born architect Kevin Roche diesAcclaimed Irish-born architect Kevin Roche dies, leaving his mark on world-class buildings from New York's Metropolitan Museum of Art and the city's Museum of Jewish Heritage to airports in New York and Washington.
Leer más »

Kevin Roche, leading corporate architect of postwar boom years, dies at 96Kevin Roche, leading corporate architect of postwar boom years, dies at 96He also became an architect of choice for the Metropolitan Museum of Art and other major institutions.
Leer más »



Render Time: 2025-03-06 16:11:17